Skip to main content

Table 3 Follow-up: Reasons for reverting to the same medication as before the N-of-1 trial

From: Conducting research in individual patients: lessons learnt from two series of N-of-1 trials

Reasons for reverting in series A

ā€ƒā€ƒā€ƒā€¢ Perceived lack of efficacy of paracetamol

ā€ƒā€ƒā€ƒā€¢ Deterioration of osteoarthritis

ā€ƒā€ƒā€ƒā€¢ Misunderstanding regarding paracetamol dosage

ā€ƒā€ƒā€ƒā€¢ Preference of small tablets (diclofenac) over larger ones (paracetamol)

ā€ƒā€ƒā€ƒā€¢ Patient found it a waste to throw away the NSAIDs she still had in her possession

Reasons for reverting in series B

ā€ƒā€ƒā€ƒā€¢ Dosage of temazepam had not been adjusted after the N-of-1 trials

ā€ƒā€ƒā€ƒā€¢ Patient sees no disadvantages in taking temazepam

  1. Series A: NSAIDs or paracetamol for osteoarthritis
  2. Series B: reduction of temazepam for sleep disturbances